3,113 press releases indexed under healthcare.
IP portfolio reflects Autonomix’s neural sensing leadership in multi-billion-dollar denervation market
PURCHASE, N.Y., July 13, 2026 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (Nasdaq: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, announced that the Company’s president and CEO, Lisa Ricciardi , has been invited to participate in a fireside discussion at the B. Riley Mind, Muscle & Vision Summit on July 16, 2026. During the discussion with analyst, William Wood, Ph.D., Ms. Ricciardi will review the status of the Company's ongoing START study as well as the planned initiation of a Phase 3 registrational study of zervimesine (CT1812) in dementia with Lewy bodies (DLB) psychosis.
DarioIQ drives higher engagement and retention, better clinical outcomes, higher client ROI and recurring revenue growth for Dario Dario IQ's AI-driven personalization increases member engagement by 40% and improves member retention by 20% by leveraging 13+ billion proprietary real-world...
WARSAW, Ind., July 13, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced its second quarter earnings conference call will be webcast on Wednesday, August 5, 2026 at 8:30 a.m. ET. A news release detailing the...
Longeveron reports new data analysis for its stem cell therapy laromestrocel in mild Alzheimer's disease at AAIC 2026.
XERF, the dual-frequency skin tightening technology that has transformed aesthetics practices in the US and Asia-Pacific, is now available across EMEA. It arrives as new consumer research reveals a spike in demand for non-invasive rejuvenation. XERF arrives in Europe following strong...
Healthcare AI, portfolio operations company KHAI Ventures has entered into a strategic distribution agreement with Wellytics Health, a healthcare technology and AI company. Under the agreement, KHAI Ventures secures unrestricted commercial and research rights to utilize, enhance, market,...
VERAXA Biotech initiates a collaboration with Ardigen SA to optimize cancer target pair selection for growing BiTAC® pipeline.
Monday 13 July, 2026 Cor Hutton has two prosthetic legs, two transplanted hands, one third of a lung and a recent kidney transplant. This August she's driving a clapped-out Audi TT to Nice. She built Scotland's amputee charity because the support she needed didn't exist. Now she's driving to fund it. Sepsis took both of Cor Hutton's hands and both of her feet. Her family never left her side. But when she looked for someone who truly understood what she was living through, she couldn't find them. So, she built Finding Your Feet. Today, Finding Your Feet (FYF) is Scotland's only nationwide charity supporting amputees, those born without limbs, and their families. It offers peer support, counselling, well-being services and inclusive clubs and activities, the kind of community that Cor needed
PRINCETON, N.J., July 13, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced positive topline data from its Phase 4, open-label, single-arm SYNCHRONICITY clinical trial of Fluocinolone Acetonide Intravitreal Implant in patients with chronic non-infectious uveitis affecting the posterior segment of the eye (chronic NIU-PS).
New app functions empower patients, caregivers and health care professionals to easily find and access Karmanos' large portfolio of innovative cancer treatment options through actively recruiting clinical trials DETROIT, July 13, 2026 /PRNewswire/ -- The Barbara Ann Karmanos Cancer...
(PR-inside.com) Expansion Scales U.S. Single-Use Drug Substance Capacity to 20,000 Liters Across Two FDA-Registered Facilities SAN DIEGO, CA / ACCESS Newswire / July 13, 2026 / Bora Biologics, a U.S.-based biologics CDMO engineered for licensed supply, today announced the expansion of its U.S. drug substance manufacturing platform through the addition of the Rockville, Maryland site. The addition strengthens the company's U.S.-anchored BioSecure commercial platform and reinforces its long-term investment in domestic biologics manufacturing. With the addition of Rockville, Bora Biologics scales its total offering of installed U.S. single-use bioreactor capacity to 20,000 liters - scalable to 30,000 liters - across two FDA-registered facilities ..